Search Results

Gout - what are the treatment options?

Authors: Schlesinger, Naomi; Dalbeth, Nicola; Perez-Ruiz, Fernando

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 8, June 2009 , pp. 1319-1328(10)

Publisher: Informa Healthcare

A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?

Authors: Lee, Ming-Han H.; Graham, Garry G.; Williams, Kenneth M.; Day, Richard O.

Source: Drug Safety, Volume 31, Number 8, 2008 , pp. 643-665(23)

Publisher: Adis International

Modulation of sinusoidal and canalicular elimination of bilirubin-glucuronides by rifampicin and other cholestatic drugs in a sandwich culture of rat hepatocytes

Authors: Lengyel, György; Veres, Zsuzsa; Tugyi, Regina; Vereczkey, László; Molnár, Tünde; Glavinas, Hristos; Krajcsi, Péter; Jemnitz, Katalin

Source: Hepatology Research, Volume 38, Number 3, March 2008 , pp. 300-309(10)

Publisher: Blackwell Publishing

Flow cytometric monitoring of multidrug drug resistance protein 1 (MRP1/ABCC1) -mediated transport of 2',7'-bis-(3-carboxypropyl)-5-(and-6)- carboxyfluorescein (BCPCF) into human erythrocyte membrane inside-out vesicles

Authors: Bobrowska-Hägerstrand, Małgorzata; Wróbel, Anna; Rychlik, Błazej; Öhman, Ida; Hägerstrand, Henry

Source: Molecular Membrane Biology, Volume 24, Numbers 5-6, September 2007 , pp. 485-495(11)

Publisher: Informa Healthcare

Excellent response to the clinical treatment of tophaceous gout

Authors: Caldas, Cezar; Fuller, Ricardo

Source: Clinical Rheumatology, Volume 26, Number 9, September 2007 , pp. 1553-1555(3)

Publisher: Springer

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

Authors: Reinders, Mattheus; Roon, Eric; Houtman, Pieternella; Brouwers, Jacobus; Jansen, Tim

Source: Clinical Rheumatology, Volume 26, Number 9, September 2007 , pp. 1459-1465(7)

Publisher: Springer

Emerging therapies in the long-term management of hyperuricaemia and gout

Authors: Stamp; O'Donnell; Chapman

Source: Internal Medicine Journal, Volume 37, Number 4, April 2007 , pp. 258-266(9)

Publisher: Blackwell Publishing

Gout in Solid Organ Transplantation: A Challenging Clinical Problem

Authors: Stamp, Lisa; Searle, Martin; O'Donnell, John; Chapman, Peter

Source: Drugs, Volume 65, Number 18, 2005 , pp. 2593-2611(19)

Publisher: Adis International

Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts

Authors: Mols, Raf; Deferme, Sven; Augustijns, Patrick

Source: Journal of Pharmacy and Pharmacology, Volume 57, Number 12, December 2005 , pp. 1565-1573(9)

Publisher: Pharmaceutical Press

Benzbromarone lowers uric acid levels and reduces acute attacks in patients with gout

Source: Inpharma, Volume 1, Number 1500, 2005-08-13 , pp. 14-14(1)

Publisher: Adis International

Management of Acute and Chronic Gouty Arthritis: Present State-of-the-Art

Author: Naomi Schlesinger

Source: Drugs, Volume 64, Number 21, 2004 , pp. 2399-2416(18)

Publisher: Adis International

d-Glucose Triggers Multidrug Resistance–Associated Protein (MRP)-Mediated Secretion of Fluorescein Across Rat Jejunum in Vitro

Authors: Legen I.; Kristl A.

Source: Pharmaceutical Research, Volume 21, Number 4, April 2004 , pp. 635-640(6)

Publisher: Springer

Uric acid: role in cardiovascular disease and effects of losartan

Authors: Alderman, Michael; Aiyer, Kala J.V.

Source: Current Medical Research and Opinion, Volume 20, Number 3, 1 March 2004 , pp. 369-379(11)

Publisher: Informa Healthcare

Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione

Authors: Bai J.; Lai L.; Yeo H.C.; Goh B.C.; Tan T.M.C.

Source: The International Journal of Biochemistry and Cell Biology, Volume 36, Number 2, February 2004 , pp. 247-257(11)

Publisher: Elsevier

Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy

Authors: Tsutsumi Z.; Moriwaki Y.; Takahashi S.; Ka T.; Yamamoto T.

Source: Clinica Chimica Acta, Volume 339, Number 1, January 2004 , pp. 117-122(6)

Publisher: Elsevier

Urate transport via human PAH transporter hOAT1 and its gene structure

Authors: Ichida, Kimiyoshi; Hosoyamada, Makoto; Kimura, Hiroaki; Takeda, Michio; Utsunomiya, Yasunori; Hosoya, Tatsuo; Endou, Hitoshi

Source: Kidney International, Volume 63, Number 1, January 2003 , pp. 143-155(13)

Publisher: Blackwell Publishing

Stopping progression in familial juvenile hyperuricemic nephropathy with benzbromarone?

Author: Lhotta, Karl

Source: Kidney International, Volume 64, Number 5, November 2003 , pp. 1920-1921(2)

Publisher: Blackwell Publishing

Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients

Authors: Boraldi F.; Quaglino D.; Croce M.A.; Garcia Fernandez M.I.; Tiozzo R.; Gheduzzi D.; Bacchelli B.; Pasquali Ronchetti I.

Source: Matrix Biology, Volume 22, Number 6, November 2003 , pp. 491-500(10)

Publisher: Elsevier

Sanofi-Synthélabo has withdrawn its hyperuricaemic product, `Desuric' [benzbromarone], in France

Source: Reactions, Volume 1, Number 952, 2003 , pp. 2-2(1)

Publisher: Adis International

Flavonoids as Inhibitors of MRP1-Like Efflux Activity in Human Erythrocytes. A Structure–Activity Relationship Study

Authors: Bobrowska-Hägerstrand M.; Wróbel A.; Mrówczyn´ska L.; Söderström T.; Shirataki Y.; Motohashi N.; Molnár J.; Michalak K.; Hägerstrand H.

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 13, Number 11, 2003 , pp. 463-469(7)

Publisher: Cognizant Communication Corporation